Ovarian cancer diagnosis and treatment

Ovarian cancer is one of the most lethal gynecologic malignancies, in part because it is rarely detected before it has spread beyond the ovary, making early diagnosis a central challenge in reproductive medicine. Researchers now understand that many ovarian tumors originate not in the ovary itself but in the fallopian tube, a shift in thinking that has reshaped how scientists model tumor development and search for early biomarkers in blood and tissue. Genomic and mutation analyses have revealed distinct molecular subtypes that respond differently to chemotherapy and cytoreductive surgery, driving efforts to match treatments to a patient's specific tumor profile rather than applying a single standard regimen. Key open questions include identifying reliable biomarkers that catch malignant changes at their earliest stages and determining how patterns of metastasis can be interrupted to improve outcomes for patients diagnosed with advanced disease.

Works

118,459

Total citations

1,405,047

Keywords

Ovarian CancerGenomic AnalysisChemotherapyCytoreductive SurgeryBiomarkersTumor Models